MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway
暂无分享,去创建一个
Beicheng Sun | H. Yang | R. Jiang | L Deng | J Tang | H Yang | C Cheng | S Lu | R Jiang | B Sun | J. Tang | Shuai Lu | Ci Cheng | S. Lu | L. Deng | B. Sun | C. Cheng | Junwei Tang | Hong Yang
[1] Xu Zhang,et al. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities , 2014, Cancer and Metastasis Reviews.
[2] K. Chayama,et al. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma , 2016, International journal of molecular sciences.
[3] Clotilde Théry,et al. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.
[4] Cheng Huang,et al. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. , 2014, Cancer letters.
[5] Y. Shin,et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells , 2008, Oncogene.
[6] K. Sugimachi,et al. The role of MTA1 gene expression in human hepatocellular carcinoma. , 2003, Oncology reports.
[7] S. Chakraborty,et al. Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma. , 2016, The American journal of pathology.
[8] Xuehao Wang,et al. Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis , 2015, Journal of Experimental & Clinical Cancer Research.
[9] B. Bao,et al. Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells , 2012, Molecular Cancer Therapeutics.
[10] G. Nicolson,et al. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. , 1994, The Journal of biological chemistry.
[11] Yaping Tian,et al. miRNA for diagnosis and clinical implications of human hepatocellular carcinoma , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[12] Kamini Singh,et al. MTA family of coregulators in nuclear receptor biology and pathology , 2007, Nuclear receptor signaling.
[13] M. Caraglia,et al. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT , 2011, Journal of cellular physiology.
[14] Da-Qiang Li,et al. Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. , 2012, Cancer research.
[15] Z. Zou,et al. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review. , 2014, Journal of immunological methods.
[16] Parul Gupta,et al. HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial‐to‐mesenchymal transition and metastasis of breast cancer , 2014, Molecular oncology.
[17] X. Bian,et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition , 2011, Gut.
[18] B. Gui,et al. Role of MTA1 in cancer progression and metastasis , 2014, Cancer and Metastasis Reviews.
[19] Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system , 2014, Cancer and Metastasis Reviews.
[20] Bin Liu,et al. Down-Regulation of MiR-30c Promotes the Invasion of Non-Small Cell Lung Cancer by Targeting MTA1 , 2013, Cellular Physiology and Biochemistry.
[21] S. McMahon,et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Isakson,et al. c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation. , 2005, International journal of oncology.
[23] P. Hotez,et al. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite‐induced cholangiocarcinoma in humans , 2011, Hepatology.
[24] C. Melief,et al. Vaccines for established cancer: overcoming the challenges posed by immune evasion , 2016, Nature Reviews Cancer.
[25] E. Yu,et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma , 2008, Hepatology.
[26] L. Mishra,et al. TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells , 2011, Oncogene.